skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Synthesis, Characterization, and Biological Activity of Hybrid Thiosemicarbazone–Alkylthiocarbamate Metal Complexes

Journal Article · · Inorganic Chemistry

A series of hybrid ligands (H2L1–H2L3) derived from 4-methyl-3-thiosemicarbazide and hydrazinecarbothioic acid O-alkyl esters were synthesized and characterized by NMR. The ligands were chelated with copper (4–6), nickel (7–9), and zinc (10–12) and characterized by spectroscopy, electrochemistry, and single crystal X-ray crystallography. The chelated metals displayed substantial anodic shifts in the CuII/I reduction potential of ~160 mV relative to their bis(thiosemicarbazone) analogues. The metal chelates 4–12 were evaluated for potential anticancer activity by MTT assays, and selected results were confirmed by clonogenic and trypan blue assays. The copper derivatives 4 and 6 were found to have potent and cancer-selective antiproliferative effects, with GI50 values less than 100 nM in A549 lung adenocarcinoma cells compared with at least 20-fold less activity in IMR90 nonmalignant lung fibroblasts. In comparison, the nickel complexes were much less active and had little cancer-selectivity. Varying by ligand, the zinc complexes were less potent or had comparable activity compared to that of the corresponding copper complex. UV–visible spectroscopy indicated that zinc complex 10 was transmetalated in the presence of equimolar copper, whereas nickel complex 7 was not. Copper complexes 4 and 6 were also assessed in the NCI60 screen and were found to have cytotoxic activity against most solid tumor cell lines. In MTT assays, 4 and 6 were substantially more active against A549 cancer cells than Cu(ATSM) and were more cancer-selective (for A549 compared to IMR-90) than Cu(GTSM). Finally, our results suggest that hybrid thiosemicarbazone–alkylthiocarbamate copper complexes have potential for development as new anticancer agents.

Research Organization:
Univ. of Louisville, KY (United States)
Sponsoring Organization:
USDOE; National Science Foundation (NSF); National Cancer Institute (NCI); National Institutes of Health (NIH)
Grant/Contract Number:
FG02-08CH11538; CHE-1665136; CHE-1800245; R25-CA134283
OSTI ID:
1800548
Journal Information:
Inorganic Chemistry, Vol. 59, Issue 7; ISSN 0020-1669
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
English

References (50)

Alzheimer's disease & metals: therapeutic opportunities journal April 2011
Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals journal January 2011
Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes journal July 2019
ColonyArea: An ImageJ Plugin to Automatically Quantify Colony Formation in Clonogenic Assays journal March 2014
The NCI60 human tumour cell line anticancer drug screen journal October 2006
Increasing Intracellular Bioavailable Copper Selectively Targets Prostate Cancer Cells journal May 2013
Copper Complexation Screen Reveals Compounds with Potent Antibiotic Properties against Methicillin-Resistant Staphylococcus aureus journal April 2014
Ternary copper(II) complex: NCI60 screening, toxicity studies, and evaluation of efficacy in xenograft models of nasopharyngeal carcinoma journal January 2018
Ligand-Assisted Metal-Centered Electrocatalytic Hydrogen Evolution upon Reduction of a Bis(thiosemicarbazonato)Ni(II) Complex journal October 2018
In Vitro and in Vivo Anticancer Activity of Copper Bis(thiosemicarbazone) Complexes journal January 2013
Copper(II)-Bis(Thiosemicarbazonato) Complexes as Antibacterial Agents: Insights into Their Mode of Action and Potential as Therapeutics journal August 2015
Structural trends in copper( ii ) bis(thiosemicarbazone) radiopharmaceuticals journal January 2003
The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson’s disease journal April 2012
Modification of Biodistribution and Brain Uptake of Copper Bis(thiosemicarbazonato) Complexes by the Incorporation of Amine and Polyamine Functional Groups journal March 2019
A novel small molecule that induces oxidative stress and selectively kills malignant cells journal March 2014
ORTEP -3 for Windows - a version of ORTEP -III with a Graphical User Interface (GUI) journal October 1997
Synthesis, Spectroscopic, and Antimicrobial Studies on Bivalent Nickel and Copper Complexes of Bis(thiosemicrbazone) journal January 2007
Cu-Pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM), a Metal Complex with Selective NADH-Dependent Reduction by Complex I in Brain Mitochondria: A Potential Radiopharmaceutical for Mitochondria-Functional Imaging with Positron Emission Tomography (PET). journal January 1995
Structure validation in chemical crystallography journal January 2009
In Vitro and In Vivo Evaluation of Bifunctional Bisthiosemicarbazone 64 Cu-Complexes for the Positron Emission Tomography Imaging of Hypoxia journal April 2008
Biophysical characterization and antineoplastic activity of new bis(thiosemicarbazonato) Cu(II) complexes journal February 2017
A short history of SHELX journal December 2007
[Cu( o -phthalate)(phenanthroline)] Exhibits Unique Superoxide-Mediated NCI-60 Chemotherapeutic Action through Genomic DNA Damage and Mitochondrial Dysfunction journal November 2015
A Perspective – can copper complexes be developed as a novel class of therapeutics? journal January 2017
Evaluation of striatal oxidative stress in patients with Parkinson's disease using [62Cu]ATSM PET journal October 2011
Synergistic Interaction of Kethoxal bis(Thiosemicarbazone) and Cupric Ions in Sarcoma 180 journal April 1966
Synthesis and in vivo behavior of a copper-64-labeled dithiosemicarbazone derivative coupled to a dihydropyridine carrier journal February 1993
Mitochondrial metabolism promotes adaptation to proteotoxic stress journal May 2019
Beyond Metal-Hydrides: Non-Transition-Metal and Metal-Free Ligand-Centered Electrocatalytic Hydrogen Evolution and Hydrogen Oxidation journal June 2016
Copper(II) and nickel(II) complexes of 2,3-butanedione bis(N(3)-substituted thiosemicarbazones) journal March 1997
The Preparation of some Thiosemicarbazones and Their Copper Complexes: part iii journal June 1962
62Cu-labeled bifunctional radiopharmaceuticals with metabolizable ester groups
  • Matsumoto, Kazuya; Fujibayashi, Yasuhisa; Arano, Yasushi
  • International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, Vol. 19, Issue 1 https://doi.org/10.1016/0883-2897(92)90182-X
journal January 1992
Evaluation of 64 Cu-Based Radiopharmaceuticals that Target Aβ Peptide Aggregates as Diagnostic Tools for Alzheimer’s Disease journal August 2017
Diagnostic Imaging Agents for Alzheimer’s Disease: Copper Radiopharmaceuticals that Target Aβ Plaques journal October 2013
Cardiac Hypoxia Imaging: Second-Generation Analogues of 64 Cu-ATSM journal January 2014
ZnII(atsm) is protective in amyotrophic lateral sclerosis model mice via a copper delivery mechanism journal September 2015
Potential Diagnostic Imaging of Alzheimer’s Disease with Copper-64 Complexes That Bind to Amyloid-β Plaques journal February 2019
Arbeiten über Phosphorsäure- und Thiophosphorsäureester mit einem heterocyclischen Substituenten. 3. Mitteilung. Thiadiazol-Ringschluss und eine dabei auftretende Methylübertragung journal April 1972
Di-copper metallodrugs promote NCI-60 chemotherapy via singlet oxygen and superoxide production with tandem TA/TA and AT/AT oligonucleotide discrimination journal February 2018
Functionalized Bis(thiosemicarbazonato) Complexes of Zinc and Copper:  Synthetic Platforms Toward Site-Specific Radiopharmaceuticals journal January 2007
Cu–ATSM: A radiopharmaceutical for the PET imaging of hypoxia journal January 2007
Exploiting Copper Redox for 19 F Magnetic Resonance-Based Detection of Cellular Hypoxia journal February 2016
Syntheses, structures, and electrochemical studies of N,N′-bis(alkylthiocarbamate)butane-2,3-diimine Cu(II) complexes as pendent alkoxy derivatives of Cu(ATSM) journal May 2017
Oral Treatment with CuII(atsm) Increases Mutant SOD1 In Vivo but Protects Motor Neurons and Improves the Phenotype of a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis journal June 2014
Reactivity of Cu( ii )–, Zn( ii )– and Fe( ii )–thiosemicarbazone complexes with glutathione and metallothionein: from stability to dissociation to transmetallation journal January 2019
Nitrogen fixation in solution journal October 1995
Antiproliferative Activity of G-rich Oligonucleotides Correlates with Protein Binding journal September 1999
Zinc(II)–Thiosemicarbazone Complexes Are Localized to the Lysosomal Compartment Where They Transmetallate with Copper Ions to Induce Cytotoxicity journal April 2016
Advances in Copper Complexes as Anticancer Agents journal September 2013
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4 journal December 2017